The mechanism of cytokeratin aggresome formation: the role of mutant ubiquitin (UBB+1)
- PMID: 12710947
- DOI: 10.1016/s0014-4800(02)00024-2
The mechanism of cytokeratin aggresome formation: the role of mutant ubiquitin (UBB+1)
Abstract
Aggresome formation in cells involves the failure of the ubiquitin-proteasome pathway to dispose of proteins destined for degradation by the 26S proteasome. UBB(+1) is present in Mallory bodies in alcoholic liver disease and in aggresomes formed in Alzheimer's desease. The present investigation focuses on the role that UBB(+1) plays in cytokeratin aggresome formation in Mallory bodies (MBs) in vitro. Immunoprecipitation with a monoclonal antibody to cytokeratin-8 (CK-8) was used. The immunoprecipitate was incubated for 24 h in the presence of different constituents involved in aggresome formation including ubiquitin, UBB(+1), the proteasome inhibitor PS341, an ATP generating energy source, a deubiquitinating enzyme inhibitor, a purified proteasome fraction, and an E(1-3) conjugating enzyme fraction. MB-like protein aggregates formed in the presence of ubiquitin, plus UBB(+1) or PS341. These aggregates stained positively for CK-8. UBB(+1), and a proteasome subunit Tbp7, as demonstrated on Western blots. A second approach was used to form MBs in vitro in cultured hepatocytes transfected with UBB(+1) protein using Chariot. The cells were double stained using CK-8 and ubiquitin antibodies. The two proteins colocalized in MB-like aggregates. The results support the possibility that aggresome formation is a complex multifactor process, which is favored by inhibition of the proteasome and by the presence of UBB(+1).
Similar articles
-
The Mallory body as an aggresome: in vitro studies.Exp Mol Pathol. 2002 Feb;72(1):17-23. doi: 10.1006/exmp.2001.2413. Exp Mol Pathol. 2002. PMID: 11784119
-
The role of the ubiquitin-proteasome pathway in the formation of mallory bodies.Exp Mol Pathol. 2002 Oct;73(2):75-83. doi: 10.1006/exmp.2002.2451. Exp Mol Pathol. 2002. PMID: 12231209
-
Heat shock proteins are present in mallory bodies (cytokeratin aggresomes) in human liver biopsy specimens.Exp Mol Pathol. 2003 Apr;74(2):168-72. doi: 10.1016/s0014-4800(02)00020-5. Exp Mol Pathol. 2003. PMID: 12710948
-
Review: unchained maladie - a reassessment of the role of Ubb(+1) -capped polyubiquitin chains in Alzheimer's disease.Neuropathol Appl Neurobiol. 2012 Apr;38(2):118-31. doi: 10.1111/j.1365-2990.2011.01236.x. Neuropathol Appl Neurobiol. 2012. PMID: 22082077 Review.
-
From Mallory to Mallory-Denk bodies: what, how and why?Exp Cell Res. 2007 Jun 10;313(10):2033-49. doi: 10.1016/j.yexcr.2007.04.024. Epub 2007 Apr 27. Exp Cell Res. 2007. PMID: 17531973 Review.
Cited by
-
Cancer-Targeting Applications of Cell-Penetrating Peptides.Int J Mol Sci. 2024 Dec 24;26(1):2. doi: 10.3390/ijms26010002. Int J Mol Sci. 2024. PMID: 39795861 Free PMC article. Review.
-
Exploring the Chemical Features and Biomedical Relevance of Cell-Penetrating Peptides.Int J Mol Sci. 2024 Dec 25;26(1):59. doi: 10.3390/ijms26010059. Int J Mol Sci. 2024. PMID: 39795918 Free PMC article. Review.
-
The role of cytokines in UbD promoter regulation and Mallory-Denk body-like aggresomes.Exp Mol Pathol. 2010 Aug;89(1):1-8. doi: 10.1016/j.yexmp.2010.04.001. Epub 2010 Apr 28. Exp Mol Pathol. 2010. PMID: 20433827 Free PMC article.
-
Characterizing polyubiquitinated forms of the neurodegenerative ubiquitin mutant UBB+1.FEBS Lett. 2016 Dec;590(24):4573-4585. doi: 10.1002/1873-3468.12484. Epub 2016 Nov 22. FEBS Lett. 2016. PMID: 27861798 Free PMC article.
-
Cauda equina neuroendocrine tumors show biological features distinct from other paragangliomas and visceral neuroendocrine tumors.Virchows Arch. 2023 Feb;482(2):325-338. doi: 10.1007/s00428-022-03441-1. Epub 2022 Nov 8. Virchows Arch. 2023. PMID: 36348031
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous